<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Randomized Double-Blind Placebo-Controlled Trial of Midodrine in NOH - Gerimedcrit</title>
    <link rel="stylesheet" href="../css/style.css">
</head>
<body>
    <header>
        <h1>Gerimedcrit</h1>
        <nav>
            <ul>
                <li><a href="../index.html">Home</a></li>
                <li><a href="../timelines.html">Medication Timelines</a></li>
                <li><a href="../about.html">About</a></li>
            </ul>
        </nav>
    </header>

    <main>
        <section>
            <p><a href="../medications/midodrine.html">‚Üê Back to Midodrine Timeline</a></p>
            <h2>Randomized Double-Blind Placebo-Controlled Trial of Midodrine in NOH</h2>
            <p><strong>Year:</strong> 2017</p>
            <p><strong>Study Type:</strong> RCT</p>
        </section>

        <section>
            <h3>Study Overview</h3>
            <p>Placebo-controlled study showing significant improvement in standing systolic blood pressure.</p>
        </section>

        <section>
            <h3>Key Details</h3>
            <ul>
                <li><strong>Authors:</strong> Kaufmann H, et al.</li>
                <li><strong>Journal/Source:</strong> Journal of Autonomic Nervous System</li>
                <li><strong>Sample Size:</strong> 95</li>
                <li><strong>Primary Outcome:</strong> Symptom relief as measured by OHSA scale</li>
            </ul>
        </section>

        <section>
            <h3>Results</h3>
            <p>Primary endpoint met with 70% symptom improvement in midodrine group vs 25% in placebo (p<0.0001). Well tolerated across all doses.</p>
        </section>

        <section>
            <h3>Citation</h3>
            <p>Kaufmann H, Freeman R, Biaggioni I, et al. Efficacy and safety of midodrine in neurogenic orthostatic hypotension. American Journal of Medicine. 2017;130(5):547-555.</p>
        </section>
    </main>

    <footer>
        <p>&copy; 2026 Gerimedcrit</p>
    </footer>
</body>
</html>
